Mesenchymal-Epithelial Transition Exon 14 Skipping Mutation and Amplification in 5,008 Patients With Lung Cancer.

Front Oncol · 2021 · PMC8515048 · PMID 34660325

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

showed a trendP = 0.058so close (0.05 < p ≤ 0.1)

MET amplification was closely related to an advanced tumor stage (III + IV, P =0.000) and showed a trend of higher mutation rate in the right lobe of the lung ( P = 0.058), which might be due to the anatomical difference of this lobe of the lung that is trilobar and the left lobe is bilobar ( 32 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.